A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on June 5, 2022 with the following interim recommendations made: Diclofenac diethylamine – for human use – when […]
NDSAC Interim Recommendations on topical diclofenac diethylamine Read More »
The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA on matters relating to the National
Invitation for Applications for NAPRA’s National Drug Scheduling Advisory Committee Read More »
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for June 5, 2022. The primary purpose of the meeting is to consider the following matter: Request
National Drug Scheduling Advisory Committee Meeting June 5, 2022 Read More »
The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on December 6, 2021 that: Brimonidine tartrate ophthalmic solution in concentrations up to and including 0.025%, used for
In accordance with its Policy for Natural Health Products (NHPs), the National Association of Pharmacy Regulatory Authorities (NAPRA) has progressed with the planned removal of NHPs from the National Drug Schedules (NDS),
Removal of Natural Health Products (NHPs) in Schedules I and II Read More »
The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 6-7, 2022 is cancelled. The next meeting of the Committee is scheduled for June 5-6, 2022. The deadline to
NDSAC Meeting of March 6-7, 2022 Read More »
A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on December 6, 2021 with the following interim recommendations made: Brimonidine tartrate ophthalmic solution in concentrations up to
*** Please note that the deadline to submit applications for NAPRA’s National Drug Scheduling Advisory Committee has been extended to November 19, 2021. The National Drug Scheduling Advisory Committee (NDSAC)
The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA on matters relating to the National Drug Schedules
Invitation for Applications for NAPRA’s National Drug Scheduling Advisory Committee Read More »
The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for December 6, 2021. The primary purpose of the meeting is to consider the following matter: Request
National Drug Scheduling Advisory Committee Meeting December 6, 2021 Read More »
